Difference between treatment-resistant schizophrenia and clozapineresistant schizophrenia  

作　　者：Ping-Tao Tseng Mu-Hong Chen Chih-Sung Liang 

机构地区：[1]Institute of Biomedical Sciences,National Sun Yat-Sen University,Kaohsiung 804,Taiwan [2]Department of Psychiatry,Taipei Veterans General Hospital,Taipei 112,Taiwan [3]Department of Psychiatry,Beitou Branch,Tri-Service General Hospital,National Defense Medical Center,Taipei 112,Taiwan

出　　处：《World Journal of Psychiatry》2022年第8期1102-1104,共3页世界精神病学杂志

摘　　要：We read the impressive review article“Clozapine resistant schizophrenia:Newer avenues of management”with great enthusiasm and appreciation.The author believes that preventing clozapine resistance from developing may be the most effective treatment strategy for patients with clozapine-resistant schizophrenia(CRS),and optimizing clozapine treatment is a key component.Disentangling the differences between treatment-resistant schizophrenia and CRS is important for studies addressing treatment strategies for these difficult-to-treat populations.

关 键 词：Treatment-resistant schizophrenia CLOZAPINE Clozapine-resistant schizophrenia Ultra-resistant schizophrenia Ultra-treatment-resistant schizophrenia Superrefractory schizophrenia 

分 类 号：R749.3[医药卫生—神经病学与精神病学]